✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

SK Biopharmaceuticals Co Ltd

Common Name
SK Biopharmaceuticals
Country
South Korea
Sector
Healthcare
Industry
Biotechnology
Employees
246
Ticker
326030
Exchange
KOREA EXCHANGE
Description
Sk Biopharmaceuticals Co., Ltd. is a leading biomedical company primarily engaged in the research, development, and commercialization of innovative pharmaceutical products. This company operates with ...

SK Biopharmaceuticals's Financial Statements Preview

Below are the financial statements of SK Biopharmaceuticals, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in trillions of KRW
2024
2023
Revenue
0.55a
0.35a
XCOPRI US
0.44a
0.27a
DP/API
0.03a
0.01a
Service revenue
0.08a
0.07a
Gross profit
0.5a
0.32a
SG&A expense
-0.41a
-0.36a
Operating profit
0.1a
-0.04a
Profit before income tax
0.07a
-0.04a
Net profit
0.23a
-0.04a
Limited Data Preview
You are viewing a limited preview of SK Biopharmaceuticals’s income statement data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind SK Biopharmaceuticals’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore SK Biopharmaceuticals’s data sources below and access millions more through our Disclosure Search.

a. SK Biopharmaceuticals's Financial Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?